Lamivudine-induced Acute Pancreatitis in a Patient with Decompensated Hbv-related Chronic Liver Disease [1]

Journal of Clinical Gastroenterology

Volumn 38, Issue 2, 2004, Pages 134-

  Soylu, Ali Riza ^a   Dökmeci, Gülbin ^a   Tezel, Ahmet ^a   Çakir, Bilge ^a   Ümit, Hasan ^a   Karahan, Nesibe ^a   Amuca, Hümeyra ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIN; FIALURIDINE; FUROSEMIDE; LAMIVUDINE; SPIRONOLACTONE;

ABDOMINAL PAIN; ACUTE PANCREATITIS; AGED; CASE REPORT; CHRONIC LIVER DISEASE; CLINICAL FEATURE; DISEASE COURSE; HEADACHE; HEPATITIS B; HUMAN; IRRITABILITY; LETTER; MALAISE; MALE; NAUSEA; PRIORITY JOURNAL;

ACUTE DISEASE; AGED; AMYLASES; FATAL OUTCOME; HEPATITIS B, CHRONIC; HUMANS; LAMIVUDINE; MALE; PANCREATITIS; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 1642498221     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200402000-00010     Document Type: Letter

References (3)

1. Brahams D. Deaths in US fialuridine trials. Lancet. 1994;343:1494-1495.
2. Dienstag JL, Perillo RP, et al. A preliminary trial of lamivudin for chronic hepatitis B infection. N Enl J Med. 1995;333:1657-1661.
3. Perry CM, Faulds D. Lamivudine: a review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in the management of HIV infection. Drugs. 1997;53:657-680.